Biochemical Mechanism of Lipid-induced Impairment of Glucose-stimulated Insulin Secretion and Reversal with a Malate Analogue
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Hyperlipidemia appears to play an integral role in loss of glucose-stimulated insulin secretion (GSIS) in type 2 diabetes. This impairment can be simulated in vitro by chronic culture of 832/13 insulinoma cells with high concentrations of free fatty acids, or by study of lipid-laden islets from Zucker diabetic fatty rats. Here we show that impaired GSIS is not a simple result of saturation of lipid storage pathways, as adenovirus-mediated overexpression of a cytosolically localized variant of malonyl-CoA decarboxylase in either cellular model results in dramatic lowering of cellular triglyceride stores but no improvement in GSIS. Instead, the glucose-induced increment in "pyruvate cycling" activity (pyruvate exchange with tricarboxylic acid cycle intermediates measured by (13)C NMR), previously shown to play an important role in GSIS, is completely ablated in concert with profound suppression of GSIS in lipid-cultured 832/13 cells, whereas glucose oxidation is unaffected. Moreover, GSIS is partially restored in both lipid-cultured 832/13 cells and islets from Zucker diabetic fatty rats by addition of a membrane permeant ester of a pyruvate cycling intermediate (dimethyl malate). We conclude that chronic exposure of islet beta-cells to fatty acids grossly alters a mitochondrial pathway of pyruvate metabolism that is important for normal GSIS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




![FIG. 5 Changes in glucose-stimulated insulin secretion, oxygen consumption, and pyruvate cycling activity induced by chronic exposure of 832/13 cells to lipids. 832/13 cells were cultured for 72 h in the presence ( + FFA ) or absence ( -FFA ) of 1 mM oleate/palmitate (2:1). A , GSIS measured by static incubation of lipid-cultured and control cells exposed to 3 or 12 mM [U13 C]glucose for 4 h. * indicates differences between lipid-cultured and control cells, at 3 and 12 mM glucose, respectively, with p < 0.01. B , oxygen consumption was measured as described under 'Materials and Methods.' * indicates that oxygen consumption was significantly higher in FFA-cultured cells than in control cells at 3 mM glucose, with p = 0.03; ** indicates that oxygen consumption was significantly lower in FFA cultured cells at 12 mM glucose than at 3 mM glucose, with p < 0.01. C , pyruvate cycling activity measured by 13 C NMR, expressed as absolute flux, calculated relative to the rate of fuel oxidation estimated from the oxygen consumption data (see 'Materials and Methods'). * indicates that cells cultured in 1 mM oleate/palmitate had increased pyruvate cycling relative to control cells at 3 mM glucose, with p < 0.004. D , endogenous substrate oxidation, calculated as described under 'Materials and Methods.' * indicates that cells cultured in 1 mM oleate/palmitate had increased endogenous substrate oxidation relative to control cells at 3 mM glucose, with p = 0.003. E , [ 13 C]glucose oxidation, calculated as described under 'Materials and Methods.' Data in all panels represent the mean ± S.E. for six independent experiments, except for oxygen consumption ( B ), which represents the mean ± S.E. for three independent experiments.](https://figures.cochat.ai/paper-figures/fc8a0daa0b3a4051a70503e322cf1ebc/biochemical-mechanism-of-lipid-induced-impairment-of-glucose-stimulated-insulin-figure-5.png)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a broader interpretation of mitochondrial dysfunction encompasses perturbations that do not necessarily compromise oxidative potential. Thus, disturbances in mitochondrial fuel selection, anaplerotic and cataplerotic carbon flux, redox balance and production of reactive oxygen species (ROS) can occur in the absence of measurable defects in respiratory capacity [4,12,65].”
From Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused? (2010) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Establishment of 2-mercaptoethanol-dependent differentiated insulin- secreting cell lines
Asfari, M., Janjic, D., Meda, P., Li, G., Halban, P. A., & Wollheim, C. B. (1992) · Endocrinology · doi:10.1210/en.130.1.167 · Cited by 1,165
Fatty acid-induced β cell apoptosis: A link between obesity and diabetes
Shimabukuro, M., Zhou, Y.-T., Levi, M., & Unger, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2498 · Cited by 1,142
Self-citationLipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications
Unger, R. H. (1995) · Diabetes · doi:10.2337/diab.44.8.863 · Cited by 1,100
Self-citationHohmeier, H. E., Mulder, H., Chen, G., Henkel-Rieger, R., Prentki, M., & Newgard, C. B. (2000) · Diabetes · doi:10.2337/diabetes.49.3.424 · Cited by 917
Self-citationContinuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2
Abu-Elheiga, L., Matzuk, M. M., Abo-Hashema, K. A. H., & Wakil, S. J. (2001) · Science · doi:10.1126/science.1056843 · Cited by 903
Lee, Y., Hirose, H., Ohneda, M., Johnson, J. H., McGarry, J. D., & Unger, R. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10878 · Cited by 836
Self-citationPoitout, V., & Robertson, R. P. (2002) · Endocrinology · doi:10.1210/endo.143.2.8623 · Cited by 743
Zhou, Y. P., & Grill, V. E. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117042 · Cited by 677
Fatty acids, lipotoxicity and insulin secretion
McGarry, J. D., & Dobbins, R. L. (1999) · Diabetologia · doi:10.1007/s001250051130 · Cited by 552
Herz, J., & Gerard, R. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.2812 · Cited by 517
Research works printed but not linked: 3
- Segall, 1999, Am. J. Physiol., 277, E521
- Jeffrey, 1996, Am. J. Physiol., 271, E788
- Sherry, 1998, 15, 59
Cited by
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
Islet cell failure in type 2 diabetes
Prentki, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29103 · Cited by 1,690
Grundy, S. M. (2011) · Atlas of Atherosclerosis and Metabolic Syndrome · doi:10.1007/978-1-4419-5839-6_1 · Cited by 1,223
Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes
Muoio, D. M., & Newgard, C. B. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2327 · Cited by 1,177
“It is now clear that these pathways are important in GSIS regulatio”
BackgroundSelf-citationGlucolipotoxicity: fuel excess and β-cell dysfunction
Poitout, V., & Robertson, R. P. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0023 · Cited by 1,092
Interplay between lipids and branched-chain amino acids in development of insulin resistance
Newgard, C. B. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.024 · Cited by 1,080
Self-citationMechanisms controlling pancreatic islet cell function in insulin secretion
Campbell, J. E., & Newgard, C. B. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00317-7 · Cited by 629
Self-citationStructure, mechanism and regulation of pyruvate carboxylase
Jitrapakdee, S., St Maurice, M., Rayment, I., Cleland, W. W., Wallace, J. C., & Attwood, P. V. (2008) · Biochemical Journal · doi:10.1042/bj20080709 · Cited by 451
Steneberg, P., Rubins, N., Bartoov-Shifman, R., Walker, M. D., & Edlund, H. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.03.007 · Cited by 411
Huffman, K. M., Shah, S. H., Stevens, R. D., Bain, J. R., Muehlbauer, M., Slentz, C. A., Tanner, C. J., Kuchibhatla, M., Houmard, J. A., Newgard, C. B., et al. (2009) · Diabetes Care · doi:10.2337/dc08-2075 · Cited by 410
Self-citationChREBP•Mlx Is the Principal Mediator of Glucose-induced Gene Expression in the Liver
Ma, L., Robinson, L. N., & Towle, H. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601576200 · Cited by 373
Maggio, C. A., & Pi-Sunyer, F. X. (2003) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(03)00071-9 · Cited by 351
Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause
Taylor, R. (2008) · Diabetologia · doi:10.1007/s00125-008-1116-7 · Cited by 352
“suppression of pyruvate cycling, which normally occurs during hyperglycaemia [19].”
Obesity-related derangements in metabolic regulation
Muoio, D. M., & Newgard, C. B. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142512 · Cited by 345
Self-citationMetabolomics Applied to Diabetes Research
Bain, J. R., Stevens, R. D., Wenner, B. R., Ilkayeva, O., Muoio, D. M., & Newgard, C. B. (2009) · Diabetes · doi:10.2337/db09-0580 · Cited by 328
“Specific resonances for each of the carbons of glutamate are affected by the population of mass isotopomers (glutamate with varying mixtures of (13)C and (12)C at each of the five carbons of the molecule), and this information can be used to calculate flux through the oxidative (PDH) and anaplerotic (PC) entry points…”
BackgroundSelf-citationMetabolic cycling in control of glucose-stimulated insulin secretion
Jensen, M. V., Joseph, J. W., Ronnebaum, S. M., Burgess, S. C., Sherry, A. D., & Newgard, C. B. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90604.2008 · Cited by 260
“The glutamate spectra obtained from -cells stimulated with [U-(13)C]glucose are used to calculate relative rates of flux through PDH and PC, thereby serving as a measure of pyruvate cycling activity (8, 28, 37).”
BackgroundMethodResultInfluentialSelf-citationRonnebaum, S. M., Ilkayeva, O., Burgess, S. C., Joseph, J. W., Lu, D., Stevens, R. D., Becker, T. C., Sherry, A. D., Newgard, C. B., & Jensen, M. V. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511908200 · Cited by 230
Self-citationβ-cell failure as a complication of diabetes
Chang-Chen, K. J., Mullur, R., & Bernal-Mizrachi, E. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9101-5 · Cited by 225
“supply blunts normal GSIS [139].”
Minireview: Implication of Mitochondria in Insulin Secretion and Action
Wiederkehr, A., & Wollheim, C. B. (2006) · Endocrinology · doi:10.1210/en.2006-0057 · Cited by 204
Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional β cells
Ferdaoussi, M., Dai, X., Jensen, M. V., Wang, R., Peterson, B. S., Huang, C., Ilkayeva, O., Smith, N., Miller, N., Hajmrle, C., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci82498 · Cited by 169
“This is consistent with the ability of a membrane-permeable analog of malate, dimethylmalate, to restore glucose-stimulated insulin secretion in lipid-cultured INS 832/13 cells or in islets from Zucker diabetic fatty rats (56).”
BackgroundSelf-citationJoseph, J. W., Jensen, M. V., Ilkayeva, O., Palmieri, F., Alárcon, C., Rhodes, C. J., & Newgard, C. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602606200 · Cited by 160
Self-citationGlycerolipid/free fatty acid cycle and islet β-cell function in health, obesity and diabetes
Prentki, M., & Madiraju, S. R. M. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.11.004 · Cited by 176
“…glycerol release, correlates with insulin secretion within the range of insulinotropic concentrations of glucose, in both rat islets and INS832/13 b-cells (Lamontagne et al., 2009; Sorhede Winzell and Ahren, 2004) and GSIS is suppressed in islets depleted of their TG stores (Boucher et al., 2004).”
Anaplerotic roles of pyruvate carboxylase in mammalian tissues
Jitrapakdee, S., Vidal-Puig, A., & Wallace, J. C. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5410-y · Cited by 149
Compensatory Responses to Pyruvate Carboxylase Suppression in Islet β-Cells
Jensen, M. V., Joseph, J. W., Ilkayeva, O., Burgess, S., Lu, D., Ronnebaum, S. M., Odegaard, M., Becker, T. C., Sherry, A. D., & Newgard, C. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604350200 · Cited by 144
Self-citationIntramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused?
Muoio, D. M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.11.007 · Cited by 137
“Thus, disturbances inmitochondrial fuel selection, anaplerotic and cataplerotic carbon flux, redox balance and production of reactive oxygen species (ROS) can occur in the absence of measurable defects in respiratory capacity [4,12,65].”
BackgroundMalic enzyme tracers reveal hypoxia-induced switch in adipocyte NADPH pathway usage
Liu, L., Shah, S., Fan, J., Park, J. O., Wellen, K. E., & Rabinowitz, J. D. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2047 · Cited by 130
Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart
Yu, X., Burgess, S. C., Ge, H., Wong, K. K., Nassem, R. H., Garry, D. J., Sherry, A. D., Malloy, C. R., Berger, J. P., & Li, C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409564102 · Cited by 94
Self-citationBagge, A., Clausen, T. R., Larsen, S., Ladefoged, M., Rosenstierne, M. W., Larsen, L., Vang, O., Nielsen, J. H., & Dalgaard, L. T. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.08.082 · Cited by 123
Kaska, L., Sledzinski, T., Chomiczewska, A., Dettlaff-Pokora, A., & Swierczynski, J. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i39.8698 · Cited by 108
Douillet, C., Currier, J., Saunders, J., Bodnar, W. M., Matoušek, T., & Stýblo, M. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.12.007 · Cited by 104
“…mM KCl, 1.2 mM KH2PO4, 1.16 mM MgSO4, 20 mM Hepes, 2.5 mM CaCl2, 0.2% bovine serum albumin, and 25.5 mM NaHCO3 (all from Sigma-Aldrich) for 1 h at 37 °C and 5% CO2, followed by a 1-hour incubation with 2.5 mM glucose (Sigma-Aldrich) and 1-hour incubation with 16.7 mM glucose (Boucher et al., 2004).”
InfluentialRegulation of core clock genes in human islets
Stamenkovic, J., Olsson, A. H., Nagorny, C. L. F., Malmgren, S., Nitert, M. D., Ling, C., & Mulder, H. (2012) · Metabolism · doi:10.1016/j.metabol.2011.11.013 · Cited by 103
“Expression of said genes was also changed in human islets under experimental conditions mimicking pathogenetic processes in β-cells [15].”
Self-citationFFAR1 Is Involved in Both the Acute and Chronic Effects of Palmitate on Insulin Secretion
Kristinsson, H., Smith, D. M., Bergsten, P., & Sargsyan, E. (2013) · Endocrinology · doi:10.1210/en.2013-1352 · Cited by 95
Matsui, J., Terauchi, Y., Kubota, N., Takamoto, I., Eto, K., Yamashita, T., Komeda, K., Yamauchi, T., Kamon, J., Kita, S., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2844 · Cited by 92
Type 2 diabetes and remission: practical management guided by pathophysiology
Taylor, R. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13214 · Cited by 81
IL-1β reciprocally regulates chemokine and insulin secretion in pancreatic β-cells via NF-κB
Burke, S. J., Stadler, K., Lu, D., Gleason, E. L., Han, A., Donohoe, D. R., Rogers, R. C., Hermann, G. E., Karlstad, M. D., & Collier, J. J. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00153.2015 · Cited by 96
“The Zucker diabetic fatty (ZDF) rat is a model of obesity and diabetes resulting from reduced functional -cell mass (4).”
BackgroundSelf-citationUnderstanding the cause of type 2 diabetes
Taylor, R. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00157-8 · Cited by 95
Islet β-cell failure in type 2 diabetes – Within the network of toxic lipids
Janikiewicz, J., Hanzelka, K., Koziński, K., Kolczyńska, K., & Dobrzyń, A. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.03.153 · Cited by 91
Herrero, L., Rubí, B., Sebastián, D., Serra, D., Asins, G., Maechler, P., Prentki, M., & Hegardt, F. G. (2005) · Diabetes · doi:10.2337/diabetes.54.2.462 · Cited by 78
“In view of the interest in the malonyl-CoA/LC-CoA model of GSIS, which is still under discussion (27,39), we directly tested the hypothesis that the malonyl-CoA/CPTI interaction is implicated in GSIS using a -cell–derived cell line overexpressing the malonyl-CoA–insensitive LCPTI.”
BackgroundRonnebaum, S. M., Jensen, M. V., Hohmeier, H. E., Burgess, S. C., Zhou, Y.-P., Qian, S., MacNeil, D., Howard, A., Thornberry, N., Ilkayeva, O., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804665200 · Cited by 77
Self-citationJoseph, J. W., Odegaard, M. L., Ronnebaum, S. M., Burgess, S. C., Muehlbauer, J., Sherry, A. D., & Newgard, C. B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706080200 · Cited by 72
Self-citationMalmgren, S., Spégel, P., Danielsson, A. P. H., Nagorny, C. L., Andersson, L. E., Nitert, M. D., Ridderstråle, M., Mulder, H., & Ling, C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.422527 · Cited by 71
“There is some disagreement with previous studies, which have shown increased respiration upon prolonged palmitate treatment (19, 58).”
BackgroundResultSelf-citationOdegaard, M. L., Joseph, J. W., Jensen, M. V., Lu, D., Ilkayeva, O., Ronnebaum, S. M., Becker, T. C., & Newgard, C. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.092593 · Cited by 70
Self-citationZhyzhneuskaya, S. V., Al-Mrabeh, A., Peters, C., Barnes, A., Aribisala, B., Hollingsworth, K. G., McConnachie, A., Sattar, N., Lean, M. E. J., & Taylor, R. (2020) · Diabetes Care · doi:10.2337/dc19-0371 · Cited by 70
What Have Metabolomics Approaches Taught Us About Type 2 Diabetes?
González-Franquesa, A., Burkart, A., ISGANAITIS, E. M., & Patti, M. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0763-1 · Cited by 77
Eckel, R. H. (2007) · Proceedings of The Nutrition Society · doi:10.1017/s0029665107005320 · Cited by 78
“The mechanism for this alteration has been attributed to lipotoxicity through a number of potential different mechanisms (Shimabukuro et al. 1998; Yaney & Corkey, 2003; Boucher et al. 2004; Joseph et al. 2004).”
BackgroundPancreatic islet inflammation: an emerging role for chemokines
Collier, J. J., Sparer, T. E., Karlstad, M. D., & Burke, S. J. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0042 · Cited by 73
Effects of ethanol on pancreatic beta-cell death: interaction with glucose and fatty acids
Dembélé, K., Nguyen, K. H., Hernandez, T. A., & Nyomba, B. L. G. (2008) · Cell Biology and Toxicology · doi:10.1007/s10565-008-9067-9 · Cited by 69
“The fatty acid mixture used in this study has been reported to be toxic to β cells (Shimabukuro et al. 1998a; Boucher et al. 2004).”
BackgroundMethodJanikiewicz, J., Hanzelka, K., Dziewulska, A., Koziński, K., Dobrzyń, P., Bernaś, T., & Dobrzyń, A. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m059980 · Cited by 68
Mechanisms of β‐cell functional adaptation to changes in workload
Wortham, M., & Sander, M. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12729 · Cited by 71
Hardy, O. T., Hohmeier, H. E., Becker, T. C., Manduchi, E., Doliba, N. M., Gupta, R. K., White, P., Stoeckert, C. J., Matschinsky, F. M., Newgard, C. B., et al. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0411 · Cited by 59
Self-citationPappan, K. L., Pan, Z., Kwon, G., Marshall, C. A., Coleman, T., Goldberg, I. J., McDaniel, M. L., & Semenkovich, C. F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409706200 · Cited by 60
Thörn, K., & Bergsten, P. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22734 · Cited by 57
“b-actin GTTACAGGAAGTCCCTCACC GGAGACCAAAGCCTTCATAC SCD1 CTTCTTGCGATACACTCTGG TGAATGTTCTTGTCGTAGGG SCD2 GCCCACTTAAACAAATGTGA TGGTACACCCTTAACGACAG DGAT1 TCGTCTGCAAGATTCTTTGT CCAGGATGCCATACTTGATA DGAT2 CCTCTTCTCCTCTGACACCT CATGGTACAGGTCGATGTCT CPT1 GCACTCCTGGAAGAAGAAGT TCTAGGGTCCGATTGATCTT FAS TGCATTGGTAGGGTACAAAG TGCTCCC…”
BackgroundWang, R., Qiu, X., Pan, R., Fu, H., Zhang, Z., Wang, Q., Chen, H., Wu, Q., Pan, X., Zhou, Y., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20211779 · Cited by 61
“Removal Removal of these stimuli could reverse most of the above-mentioned cellular responses, leading to the restoration of β cell function (Boucher et al., 2004; Moffitt et al., 2005; Pinnick et al., 2010).”
Parton, L. E., McMillen, P. J., Shen, Y., Docherty, E., Sharpe, E., Diraison, F., Briscoe, C. P., & Rutter, G. A. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00067.2006 · Cited by 57
“To explore in more detail the possible reasons underlying the inability of SREBP-1c DN to rescue GSIS, we analyzed here the expression of several key -cell transcription factors.”
BackgroundInfluentialPinnick, K., Neville, M., Clark, A., & Fielding, B. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22445 · Cited by 55
“There is limited evidence to suggest that the removal of exogenous FA results in the recovery of stimulated insulin secretion in vitro [Zhou and Grill, 1994; Boucher et al., 2004].”
BackgroundSteven, S., Carey, P. E., Small, P. K., & Taylor, R. (2015) · Diabetic Medicine · doi:10.1111/dme.12567 · Cited by 55
Heart, E. A., Cline, G. W., Collis, L. P., Pongratz, R. L., Gray, J. P., & Smith, P. J. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90836.2008 · Cited by 58
“In addition, we tested the effect of ME1 overexpression on the potentiating effect of DMM on GSIS, proposed earlier to occur via activation of pyruvate cycling pathways (5).”
BackgroundMethodLipotoxic Impairment of Mitochondrial Function in β-Cells: A Review
Römer, A., Linn, T., & Petry, S. F. (2021) · Antioxidants · doi:10.3390/antiox10020293 · Cited by 57
“The impaired enzymes, among others the citrate synthase [78], cause a shortage of intermediates required for the TCA cycle like oxaloacetate, citrate, and α-ketoglutarate [79], which might also be caused by a reduced activity of pyruvate carboxylase [80–82], and is also directly proportional to GSIS [83].”
BackgroundInfluentialMitochondrial bioenergetics, metabolism, and beyond in pancreatic β-cells and diabetes
Nieves, A. M. R., Wauford, B. M., & Fu, A. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1354199 · Cited by 57
Soni, M. S., Rabaglia, M. E., Bhatnagar, S., Shang, J., Ilkayeva, O., Mynatt, R. L., Zhou, Y., Schadt, E. E., Thornberry, N. A., Muoio, D. M., et al. (2014) · Diabetes · doi:10.2337/db13-1677 · Cited by 54
“(28) showed that overexpression of malonyl-CoA decarboxylase leads to increased b-oxidation without affecting IS.”
BackgroundRonnebaum, S. M., Joseph, J. W., Ilkayeva, O., Burgess, S. C., Lu, D., Becker, T. C., Sherry, A. D., & Newgard, C. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800119200 · Cited by 53
Self-citationMetabolic syndrome: anesthesia for morbid obesity
Neligan, P. J. (2010) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e328338caa0 · Cited by 56
(Anti)Fragility and Convex Responses in Medicine
Taleb, N. N. (2018) · Springer proceedings in complexity · doi:10.1007/978-3-319-96661-8_32 · Cited by 50
Seeley, R. J., & York, D. A. (2005) · Obesity Reviews · doi:10.1111/j.1467-789x.2005.00193.x · Cited by 43
“Fatty acid exposure also results in reduced pyruvate cycling and the application of a pyruvate cycling intermediate, dimethyl malate, results in increased pyruvate cycling and completely restores the ability of these cells to respond to increased glucose with robust insulin secretion ( 8 ).”
BackgroundWorking with Convex Responses: Antifragility from Finance to Oncology
Taleb, N. N., & West, J. (2023) · Entropy · doi:10.3390/e25020343 · Cited by 47
“(2004) [42]; diabetes management by diet alone, early insights in Wilson et al.”
BackgroundIslet b cell failure in type 2 diabetes
Prentki, M., & Nolan, C. J. (2006) · Cited by 47
Pregnancy to postpartum transition of serum metabolites in women with gestational diabetes
Chorell, E., Andersson-Hall, U. K., Gustavsson, C., Berntorp, K. E., Puhkala, J., Luoto, R. M., Olsson, T., & Holmäng, A. B. (2017) · Metabolism · doi:10.1016/j.metabol.2016.12.018 · Cited by 45
Wu, W., Shang, J., Feng, Y., Thompson, C. M., Horwitz, S., Thompson, J. R., MacIntyre, E. D., Thornberry, N. A., Chapman, K. T., Zhou, Y.-P., et al. (2008) · SLAS DISCOVERY · doi:10.1177/1087057107313763 · Cited by 39
Metabolomics applied to the pancreatic islet
Gooding, J. R., Jensen, M. V., & Newgard, C. B. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.06.013 · Cited by 37
“The mechanism of GSIS inhibition is therefore more complex than “overstorage” of triacylglycerols [23].”
BackgroundSelf-citationOrphan nuclear receptors: therapeutic opportunities in skeletal muscle
Smith, A. G., & Muscat, G. E. O. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00476.2005 · Cited by 36
“Several mechanisms have been proposed to underlie pancreatic lipotoxicity in metabolic syndrome (17, 69, 188).”
BackgroundFord, S. M., Simon, L., Stouwe, C. V., Allerton, T. D., Mercante, D. E., Byerley, L. O., Dufour, J., Bagby, G. J., Nelson, S., & Molina, P. E. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00142.2016 · Cited by 37
“Previous studies demonstrated that prolonged exposure of pancreatic -cells to increased fatty acid concentrations reduces GSIS (8, 31).”
BackgroundInfluentialJohn, A. N., & Jiang, F. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.12.002 · Cited by 43
Singh, S. P., Niemczyk, M., Zimniak, L., & Zimniak, P. (2008) · Aging · doi:10.18632/aging.100005 · Cited by 37
“In fact, experimental lowering of malonyl-CoA levels results in a lean phenotype in mammals [37-39] as well as in C.”
BackgroundDGAT1 inhibitors protect pancreatic β-cells from palmitic acid-induced apoptosis
Huang, J., Guo, B., Wang, G., Zeng, L.-M., Hu, Y., Wang, T., & Wang, H. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0482-7 · Cited by 29
Protective effect of leg fat against cardiovascular risk factors in obese premenopausal women
Faloia, E., Tirabassi, G., Canibus, P., & Boscaro, M. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.02.004 · Cited by 30
Metabolomics Analysis of Nutrient Metabolism in β-Cells
Spégel, P., & Mulder, H. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.07.020 · Cited by 26
Self-citationJensen, M. V., Haldeman, J. M., Zhang, H., Lu, D., Huising, M. O., Vale, W., Hohmeier, H. E., Rosenberg, P. B., & Newgard, C. B. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.491654 · Cited by 26
“Exposure of 832/13 cells to chronic elevations of fatty acids, another model of impaired GSIS and dysregulated pyruvate cycling (6), also caused a decrease in Kv2.”
BackgroundMethodResultSelf-citationRohli, K. E., Boyer, C. K., Bearrows, S. C., Moyer, M. R., Elison, W. S., Bauchle, C. J., Blom, S. E., Yu, C.-L., Pope, M. R., 张建朝, et al. (2022) · Function · doi:10.1093/function/zqac051 · Cited by 24
Fetuin‐A excess expression amplifies lipid induced apoptosis and β‐cell damage
Mukhuty, A., Fouzder, C., & Kundu, R. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30499 · Cited by 23
Zoppi, C. C., Silveira, L. R., de Oliveira, C. A. M., Boschero, A. C., Curi, R., & Carneiro, E. M. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509993060 · Cited by 25
“In 832/13 insulinoma cells treated with high concentrations of NEFA, GIIS is significantly reduced in association with a decreased mitochondrial anaplerosis– cataplerosis cycle((9)).”
BackgroundChoi, S., Lee, Y.-J., Hwang, G., Chung, J. H., Lee, S., Lee, J.-H., Han, S. J., Kim, H. J., Lee, K. W., Kim, Y., et al. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.10.011 · Cited by 22
Nyblom, H. K., Nord, L. I., Andersson, R., Kenne, L., & Bergsten, P. (2007) · NMR in Biomedicine · doi:10.1002/nbm.1197 · Cited by 23
“An indication that the two phenomena may also have separate mechanistic backgrounds, at least in part, is shown by the fact that the increase in basal insulin secretion observed after exposure to raised concentrations of glucose and non-esterified fatty acids (24,34,35) was not seen after exposure to increased glucose…”
BackgroundIn vivo and in vitro microdialysis sampling of free fatty acids
Jensen, S. M., Hansen, H. S., Johansen, T., & Malmlöf, K. (2006) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2006.12.014 · Cited by 23
Palmitate-induced changes in protein expression of insulin secreting INS-1E cells
Hovsepyan, M., Sargsyan, E., & Bergsten, P. (2010) · Journal of Proteomics · doi:10.1016/j.jprot.2010.01.012 · Cited by 22
McClenaghan, N. H., Scullion, S. M., Mion, B., Hewage, C. M., Malthouse, J. P. G., Flatt, P. R., Newsholme, P., & Brennan, L. (2008) · Clinical Science · doi:10.1042/cs20080138 · Cited by 22
Identification of early biological changes in palmitate-treated isolated human islets
Sargsyan, E., Cen, J., Roomp, K., Schneider, R., & Bergsten, P. (2018) · BMC Genomics · doi:10.1186/s12864-018-5008-z · Cited by 20
Jazurek, M., Janikiewicz, J., Dobrzyń, P., Dziewulska, A., Koziński, K., & Dobrzyń, A. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.06.018 · Cited by 18
A metabolic redox relay supports ER proinsulin export in pancreatic islet β cells
Rohli, K. E., Stubbe, N. J., Walker, E. M., Pearson, G. L., Soleimanpour, S. A., & Stephens, S. B. (2024) · JCI Insight · doi:10.1172/jci.insight.178725 · Cited by 20
“Note that the addition of oleate allows for prolonged exposure to fatty acid, which exacerbates β cell dysfunction but not β cell death (33–36).”
Pdcd2l Promotes Palmitate-Induced Pancreatic Beta-Cell Apoptosis as a FoxO1 Target Gene
Yin, Y., Wei, Y. Q., Yu, J., Zhang, X., Lin, H., Zhu, Y., & Han, X. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166692 · Cited by 16
Scharp, D. W., Arulmoli, J., Morgan, K. N., Sunshine, H., & Hao, E. (2019) · OBM Transplantation · doi:10.21926/obm.transplant.1901052 · Cited by 17
A mathematical model of the mitochondrial NADH shuttles and anaplerosis in the pancreatic β-cell
Westermark, P. O., Kotaleski, J. H., Björklund, A., Grill, V., & Lansner, A. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00589.2005 · Cited by 15
Modulation of Insulin Secretion by Fatty Acyl Analogs
Las, G., Mayorek, N., Dickstein, K., & Bar‐Tana, J. (2006) · Diabetes · doi:10.2337/db06-0687 · Cited by 13
Hoang, M., Paglialunga, S., Bombardier, É., Tupling, A. R., & Joseph, J. W. (2019) · Endocrinology · doi:10.1210/en.2018-00936 · Cited by 12
Insulin secretion is increased in non‐diabetic subjects with fasting hypertriglyceridaemia
Simental‐Mendía, L. E., Rodríguez‐Morán, M., Simental‐Saucedo, L., & Guerrero‐Romero, F. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2379 · Cited by 12
Suppression of FAT/CD36 mRNA by human growth hormone in pancreatic β-cells
Dalgaard, L. T., Thams, P., Gaarn, L. W., Jensen, J., Lee, Y. C., & Nielsen, J. H. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.010 · Cited by 12
Okazaki, Y., Kazuhiro, E. T. O., Yamashita, T., Okamoto, M., Ohsugi, M., Noda, M., Terauchi, Y., Ueki, K., & Kadowaki, T. (2010) · Endocrine Journal · doi:10.1507/endocrj.k09e-284 · Cited by 12
Taylor, R. (2011) · Practical Diabetes · doi:10.1002/pdi.1639 · Cited by 11
The eSS rat, a nonobese model of disordered glucose and lipid metabolism and fatty liver
Daniele, S. M., Montenegro, S. M., Tarrés, M. C., Picena, J. C., & Martínez, S. M. (2010) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-2-15 · Cited by 9
Shi, R., Hu, J., Li, W., Wang, Z., Pan, Y., Bai, M., Mao, W., Wang, X., Zhong, M., Yuan, Y., et al. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111613 · Cited by 10
Metadata
- Authors
- Boucher, A., Lu, D., Burgess, S. C., Telemaque-Potts, S., Jensen, M. V., Mulder, H., Wang, M.-Y., Unger, R. H., Sherry, A. D., & Newgard, C. B.
- Affiliations
- Duke University (US)
- The University of Texas Southwestern Medical Center (US)
- Lund University (SE)
- Corresponding author
- Newgard, Christopher B.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-06
- Volume
- 279
- Issue
- 26
- Pages
- 27263-27271
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2049564955
- Cited by
- 136
- References
- 45
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 2 · 2022: 4 · 2021: 4 · 2020: 3 · 2019: 5 · 2018: 3 · 2017: 3 · 2016: 8 · 2015: 5 · 2014: 3 · 2013: 4 · 2012: 7
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5961 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- National Institutes of Health (HL34557)
- National Heart, Lung, and Blood Institute (HL34557)
- National Institute of Diabetes and Digestive and Kidney Diseases (P01DK058398, R01-DK-42582, P01 DK58398)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- glucose-stimulated insulin secretion, hyperlipidemia, type 2 diabetes, free fatty acids, malonyl-CoA decarboxylase, beta-cell dysfunction, triglyceride storage, Zucker diabetic fatty rats
- MeSH terms
- Insulin Secretion, Adenoviridae, Animals, Carboxy-Lyases, Cell Line, Glucose, Insulin, Islets of Langerhans, Malates, Male, Oxygen Consumption, Palmitates, Rats, Zucker, Transduction, Genetic, Triglycerides, Pyruvic Acid, Oleic Acid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.